Department of Pharmaceuticals and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia.
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia.
Vasc Health Risk Manag. 2024 Aug 24;20:403-413. doi: 10.2147/VHRM.S467656. eCollection 2024.
This study aimed to examine the quality of life of patients receiving warfarin therapy at Dr. Hasan Sadikin Central General Hospital, and its relationship with demographic factors.
The procedures started with the submission of a study permit, followed by validation of the Duke Anticoagulation Satisfaction Scale (DASS) questionnaire. In addition, the validated questionnaire was completed by the participants, and significant variables were analyzed using the chi-square method for multivariate analysis.
The results showed that the questionnaire was valid and could be used for further analyses. Among the 88 selected participants, 52 and 36 had scoring categories <56.266 and 56.266 ≤ x ≤ 143.734, respectively, with no patients having a scoring category > 143.734. In addition, participants with low education and aged ≥ 52 years were 4.916 and 3.161 times more at risk of having quality of life score of 56.266 ≤ x ≤ 143.734, respectively. Based on the results, the average quality of life score of patients was 59.66. Participants with low educational levels and those aged ≥ 52 years were at a higher risk of having quality of life score of 56.266 ≤ x ≤ 143.734.
In summary, a lower quality of life score was linked to increased comfort and satisfaction among patients receiving warfarin treatment. Additionally, these patients experienced fewer feelings of limitations and inconveniences related to their treatment plans.
本研究旨在探讨在 Hasan Sadikin 中央综合医院接受华法林治疗的患者的生活质量及其与人口统计学因素的关系。
该研究首先提交了一份研究许可,随后对 Duke 抗凝满意度量表(DASS)问卷进行了验证。此外,参与者还完成了经过验证的问卷,并且使用卡方检验对多变量分析中的显著变量进行了分析。
结果表明问卷是有效的,可以用于进一步分析。在 88 名选定的参与者中,52 名和 36 名的评分类别分别为<56.266 和 56.266≤x≤143.734,没有评分类别>143.734 的患者。此外,受教育程度较低和年龄≥52 岁的参与者发生生活质量评分 56.266≤x≤143.734 的风险分别为 4.916 倍和 3.161 倍。基于这些结果,患者的平均生活质量评分为 59.66。受教育程度较低和年龄≥52 岁的参与者发生生活质量评分 56.266≤x≤143.734 的风险更高。
总之,生活质量评分较低与接受华法林治疗的患者的舒适度和满意度增加有关。此外,这些患者在治疗计划方面的限制和不便感较少。